MX9700860A - Inhibicion de la biosintesis de leucotrienos con derivados de urea. - Google Patents

Inhibicion de la biosintesis de leucotrienos con derivados de urea.

Info

Publication number
MX9700860A
MX9700860A MX9700860A MX9700860A MX9700860A MX 9700860 A MX9700860 A MX 9700860A MX 9700860 A MX9700860 A MX 9700860A MX 9700860 A MX9700860 A MX 9700860A MX 9700860 A MX9700860 A MX 9700860A
Authority
MX
Mexico
Prior art keywords
leukotriene biosynthesis
inhibition
urea derivatives
compound
pharmaceutical composition
Prior art date
Application number
MX9700860A
Other languages
English (en)
Other versions
MXPA97000860A (es
Inventor
Stephen L Crooks
Bryon A Merrill
Paul D Wightman
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,643 external-priority patent/US5612377A/en
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of MX9700860A publication Critical patent/MX9700860A/es
Publication of MXPA97000860A publication Critical patent/MXPA97000860A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Un método para inhibir la biosíntesis de leucotrienos, que incluye administrar un compuesto de la formula I en donde M, R, R', R" y n son como se definen aquí. También una composicion farmacéutica que incluye ese compuesto y el uso de ese compuesto en la fabricacion de una composicion farmacéutica para inhibir la biosíntesis de leucotrienos.
MXPA/A/1997/000860A 1994-08-04 1997-02-03 Inhibicion de la biosintesis de leucotrienos con derivados de urea MXPA97000860A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US28601794A 1994-08-04 1994-08-04
US286017 1994-08-04
US08/455,643 US5612377A (en) 1994-08-04 1995-05-31 Method of inhibiting leukotriene biosynthesis
US4556432 1995-05-31
US08455643 1995-05-31
PCT/US1995/007667 WO1996003983A1 (en) 1994-08-04 1995-07-14 Inhibition of leukotriene biosynthesis with urea derivatives

Publications (2)

Publication Number Publication Date
MX9700860A true MX9700860A (es) 1997-10-31
MXPA97000860A MXPA97000860A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
IL114646A (en) 2000-02-29
FI970452A (fi) 1997-02-03
CZ31297A3 (en) 1997-09-17
DE69528984D1 (de) 2003-01-09
EP0777471A1 (en) 1997-06-11
AU685980B2 (en) 1998-01-29
IL114646A0 (en) 1995-11-27
AU3091795A (en) 1996-03-04
NO970477D0 (no) 1997-02-03
ES2185708T3 (es) 2003-05-01
EP0777471B1 (en) 2002-11-27
HUT76830A (en) 1997-11-28
NO970477L (no) 1997-03-14
PT777471E (pt) 2003-04-30
ATE228359T1 (de) 2002-12-15
PL180668B1 (pl) 2001-03-30
BR9508521A (pt) 1997-10-28
SK11097A3 (en) 1997-09-10
DE69528984T2 (de) 2003-09-04
WO1996003983A1 (en) 1996-02-15
CA2196701A1 (en) 1996-02-15
JPH10503771A (ja) 1998-04-07
PL318539A1 (en) 1997-06-23
NZ290236A (en) 1998-12-23
CZ287034B6 (en) 2000-08-16
NO315786B1 (no) 2003-10-27
DK0777471T3 (da) 2003-03-17
FI970452A0 (fi) 1997-02-03
SK282777B6 (sk) 2002-12-03

Similar Documents

Publication Publication Date Title
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
GEP20033000B (en) 2-Substituted-1-Piperidyl Benzimidazole Compounds as ORL1-Receptor Agonists
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
HK1026909A1 (en) Substituted phenyl derivatives, their preparation and use
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
BG103947A (en) Derivatives of 9-oxymerythromycin
BG103268A (en) Propionic acid derivatives and their application
IE890906L (en) Method of lowering the blood pressure
AP9701041A0 (en) Pyridylpyrrole compounds.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
GEP20032953B (en) Antitumor Agents
MX9708696A (es) Cefalosporinas antibacterianas.
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
AU7498494A (en) New bis-naphthalimides for the treatment of cancer
AU5754294A (en) Use of a pregnane derivative
AU5390900A (en) Potassium channel blocking agents
AU3091795A (en) Inhibition of leukotriene biosynthesis with urea derivatives
WO1997013776A3 (fr) Nouveaux derives amines de 2&#39;, 3&#39; didesoxyglycosides d&#39;epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux
MY115430A (en) Glutaramide derivatives.
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
IL109227A0 (en) Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees